3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
22
Leukemia
19
Leukemia, Myeloid, Chronic-Phase
16
Breast Neoplasms
11
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
8
Blast Crisis
8
Prostatic Neoplasms
7
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Recurrence
5
Pancreatic Neoplasms
5
Leukemia, Myeloid, Accelerated Phase
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Melanoma
4
Gliosarcoma
4
Glioblastoma
4
Rectal Neoplasms
3
Philadelphia Chromosome
3
Lung Neoplasms
3
Glioma
3
Gastrointestinal Stromal Tumors
3
Colorectal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Sarcoma
2
Salivary Gland Neoplasms
2
Ovarian Neoplasms
2
Myelodysplastic Syndromes
2
Interventions
Cyclophosphamide
56
Etoposide
40
Filgrastim
37
Carboplatin
34
Vincristine
30
Doxorubicin
30
Melphalan
27
Topotecan
25
Isotretinoin
24
Peripheral Blood Stem Cell Transplantation
23
Granulocyte Colony-Stimulating Factor
22
Cisplatin
21
Irinotecan
20
sargramostim
18
Temozolomide
17
humanized 3F8 anti-GD2 monoclonal antibody
15
Radiotherapy
15
3-Iodobenzylguanidine
13
Granulocyte-Macrophage Colony-Stimulating Factor
11
Busulfan
11
dinutuximab
10
Interleukin-2
9
aldesleukin
8
Thiotepa
8
Ifosfamide
8
etoposide phosphate
7
Mesna
7
Vorinostat
6
Stem Cell Transplantation
6
Polymerase Chain Reaction
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neuroblastoma
×
Dasatinib
×
Clear all
NCT01467986
2020-10-06
RIST-rNB-2011
University of Regensburg
Phase 2
Completed
130 enrolled